Hops — Benefits Deep Dive

Hops are a strange case among medicinal herbs. Almost everyone has consumed them, in beer; they are approved in Europe as a traditional herbal medicine for stress and sleep; one of their compounds is among the most powerful plant oestrogens ever measured; another is the subject of hundreds of laboratory papers on cancer, metabolism and skin. And yet the core clinical question — what do hops, on their own, do for people? — has barely been tested.

These four articles set out what is actually established. In short: valerian–hops combinations have modest, partly positive results for mild insomnia, and two trials of other hop-containing mixtures were negative; one small pilot trial found that hops alone reduced stress, anxiety and depression scores in young adults; menopause trials of the hop phytoestrogen 8-prenylnaringenin (8-PN) conflict, and reviews disagree about them; xanthohumol research is overwhelmingly preclinical; and the most serious safety finding concerns dogs, for whom eating hops can cause fatal hyperthermia.


Deep-Dive Articles

Table of Contents

  1. Deep-Dive Articles
  2. The Position, in One Page
  3. Evidence Ledger at a Glance
  4. Key Research: Sleep
  5. Key Research: Stress, Anxiety and Mood
  6. Key Research: 8-Prenylnaringenin and Hormones
  7. Key Research: Xanthohumol and Other Hop Compounds
  8. Key Research: Safety
  9. External Resources
  10. Connections
  11. Featured Videos

The Position, in One Page

What is solid

What is not

A point that is easy to miss

Two randomised trials of hop-containing mixtures — one with fatty acids, one with a five-ingredient complex — found no difference from placebo, partly because people taking placebo improved a great deal. Insomnia trials have large placebo responses, which is why uncontrolled reports of herbal sleep aids are hard to interpret.

Back to Table of Contents

Evidence Ledger at a Glance

Ranked by how well established each item is.

  1. Established, human: hops are a common food ingredient through beer; LactMed reports generally recognized as safe (GRAS) status as a food in the United States.
  2. Established, veterinary: hops toxicosis in dogs, with hyperthermia in up to 96% of affected dogs in one series and deaths in every series.
  3. Modest, human, combination only: valerian–hops for mild insomnia.
  4. Negative, human, combination: two hop-containing sleep mixtures no better than placebo.
  5. Positive pilot, human, hops alone: lower stress, anxiety and depression scores in 36 young adults over four weeks.
  6. Conflicting, human: 8-PN for menopausal hot flushes.
  7. Human, pharmacokinetic and marker: xanthohumol absorption; reduced inflammatory response of blood cells in the lab after a dietary-level dose; better artery function for two hours after isohumulones.
  8. Animal: xanthohumol effects on weight, blood fats and blood sugar; 8-PN oestrogenic effects on the uterus and pituitary hormones.
  9. Cell culture: xanthohumol anticancer, antibacterial, anti-pigment and anti-inflammatory effects; liver-enzyme inhibition by valerian–hops extracts.
  10. Absent: hops-alone sleep trials, long-term hormonal safety, pregnancy and breastfeeding data, interaction studies in people.

Back to Table of Contents

Key Research: Sleep

  1. Morin CM, Koetter U, Bastien C, et al. Valerian-hops combination and diphenhydramine for treating insomnia: a randomized placebo-controlled clinical trial. Sleep. 2005;28(11):1465-71. PubMed PMID: 16335333
  2. Schicktanz N, Gerhards C, Schlitt T, et al. Effects of a Valerian-Hops Extract Combination (Ze 91019) on Sleep Duration and Daytime Cognitive and Psychological Parameters in Occasional Insomnia: A Randomized Controlled Feasibility Trial. Brain and behavior. 2025;15(6):e70600. PubMed PMID: 40462685
  3. Maroo N, Hazra A, Das T. Efficacy and safety of a polyherbal sedative-hypnotic formulation NSF-3 in primary insomnia in comparison to zolpidem: a randomized controlled trial. Indian journal of pharmacology. 2013;45(1):34-9. PubMed PMID: 23543804
  4. Cornu C, Remontet L, Noel-Baron F, et al. A dietary supplement to improve the quality of sleep: a randomized placebo controlled trial. BMC complementary and alternative medicine. 2010;10:29. PubMed PMID: 20569455
  5. Scholey A, Benson S, Gibbs A, et al. Exploring the Effect of Lactium™ and Zizyphus Complex on Sleep Quality: A Double-Blind, Randomized Placebo-Controlled Trial. Nutrients. 2017;9(2). PubMed PMID: 28218661
  6. Franco L, Sánchez C, Bravo R, et al. The sedative effect of non-alcoholic beer in healthy female nurses. PloS one. 2012;7(7):e37290. PubMed PMID: 22815680
  7. Salter S, Brownie S. Treating primary insomnia - the efficacy of valerian and hops. Australian family physician. 2010;39(6):433-7. PubMed PMID: 20628685
  8. Borrás S, Martínez-Solís I, Ríos JL. Medicinal Plants for Insomnia Related to Anxiety: An Updated Review. Planta medica. 2021;87(10-11):738-753. PubMed PMID: 34116572
  9. Yeom JW, Cho CH. Herbal and Natural Supplements for Improving Sleep: A Literature Review. Psychiatry investigation. 2024;21(8):810-821. PubMed PMID: 39086164
  10. Unger M. [Botanical sedatives]. Pharmazie in unserer Zeit. 2007;36(3):206-12. PubMed PMID: 17555057

PubMed Topic Searches

  1. PubMed: Valerian and hops for insomnia

Back to Table of Contents

Key Research: Stress, Anxiety and Mood

  1. Kyrou I, Christou A, Panagiotakos D, et al. Effects of a hops (Humulus lupulus L.) dry extract supplement on self-reported depression, anxiety and stress levels in apparently healthy young adults: a randomized, placebo-controlled, double-blind, crossover pilot study. Hormones (Athens, Greece). 2017;16(2):171-180. PubMed PMID: 28742505
  2. Kenda M, Kočevar Glavač N, Nagy M, et al. Medicinal Plants Used for Anxiety, Depression, or Stress Treatment: An Update. Molecules (Basel, Switzerland). 2022;27(18). PubMed PMID: 36144755

Back to Table of Contents

Key Research: 8-Prenylnaringenin and Hormones

A 2023 randomised trial in Iran compared a vaginal gel containing hop extract with vaginal estradiol (0.625 mg) for sexual problems after menopause in 63 postmenopausal women (33 in the hop group, 30 in the estradiol group). Scores on the Female Sexual Function Index did not differ significantly between the two groups after treatment, and the authors report no adverse events. There was no placebo group, so the trial shows only that the two treatments did not differ.

  1. Štulíková K, Karabín M, Nešpor J, et al. Therapeutic Perspectives of 8-Prenylnaringenin, a Potent Phytoestrogen from Hops. Molecules (Basel, Switzerland). 2018;23(3). PubMed PMID: 29543713
  2. Depypere HT, Comhaire FH. Herbal preparations for the menopause: beyond isoflavones and black cohosh. Maturitas. 2014;77(2):191-4. PubMed PMID: 24314619
  3. Abdi F, Mobedi H, Roozbeh N. Hops for Menopausal Vasomotor Symptoms: Mechanisms of Action. Journal of menopausal medicine. 2016;22(2):62-4. PubMed PMID: 27617238
  4. Kenda M, Glavač NK, Nagy M, et al. Herbal Products Used in Menopause and for Gynecological Disorders. Molecules (Basel, Switzerland). 2021;26(24). PubMed PMID: 34946512
  5. Dietz BM, Hajirahimkhan A, Dunlap TL, et al. Botanicals and Their Bioactive Phytochemicals for Women's Health. Pharmacological reviews. 2016;68(4):1026-1073. PubMed PMID: 27677719
  6. Cos P, De Bruyne T, Apers S, et al. Phytoestrogens: recent developments. Planta medica. 2003;69(7):589-99. PubMed PMID: 12898412
  7. Vahedpoorfard Z, Ferdosi S, Rahimi H, et al. Effect of Humulus lupulus L. (Hop) on Postmenopausal Sexual Dysfunction: A Randomized Clinical Trial. International journal of clinical practice. 2023;2023:9528335. PubMed PMID: 37101856

PubMed Topic Searches

  1. PubMed: 8-Prenylnaringenin and menopause

Back to Table of Contents

Key Research: Xanthohumol and Other Hop Compounds

In a 2026 triple-masked, randomised, placebo-controlled phase 2 trial, 20 adults with active Crohn's disease took 24 mg of xanthohumol a day or a placebo for 8 weeks. The main outcomes were safety measures: laboratory tests, vital signs and side effects. The researchers report that xanthohumol at 24 mg a day “was safe and well tolerated”, with no serious side effects attributed to it in either group. A second report from the same trial (19 people completed it) found that in the xanthohumol group, falls in secondary bile acids and rises in IL-10 (interleukin-10) went together with improved Crohn's Disease Activity Index scores — an association in a small trial, not proof of benefit.

  1. Stevens JF, Page JE. Xanthohumol and related prenylflavonoids from hops and beer: to your good health! Phytochemistry. 2004;65(10):1317-30. PubMed PMID: 15231405
  2. Legette L, Karnpracha C, Reed RL, et al. Human pharmacokinetics of xanthohumol, an antihyperglycemic flavonoid from hops. Molecular nutrition & food research. 2014;58(2):248-55. PubMed PMID: 24038952
  3. Neumann HF, Frank J, Venturelli S, et al. Bioavailability and Cardiometabolic Effects of Xanthohumol: Evidence from Animal and Human Studies. Molecular nutrition & food research. 2022;66(6):e2100831. PubMed PMID: 34967501
  4. Jung F, Staltner R, Tahir A, et al. Oral intake of xanthohumol attenuates lipoteichoic acid-induced inflammatory response in human PBMCs. European journal of nutrition. 2022;61(8):4155-4166. PubMed PMID: 35857130
  5. Girisa S, Saikia Q, Bordoloi D, et al. Xanthohumol from Hop: Hope for cancer prevention and treatment. IUBMB life. 2021;73(8):1016-1044. PubMed PMID: 34170599
  6. Kołodziejczak A, Dziedzic M, Algiert-Zielińska B, et al. A Novel Look at Mechanisms and Applications of Xanthohumol (XN) in Dermatology and Cosmetology. International journal of molecular sciences. 2024;25(22). PubMed PMID: 39596008
  7. Chen W, Becker T, Qian F, et al. Beer and beer compounds: physiological effects on skin health. Journal of the European Academy of Dermatology and Venereology : JEADV. 2014;28(2):142-50. PubMed PMID: 23802910
  8. Tomita J, Mochizuki S, Fujimoto S, et al. Acute improvement of endothelial functions after oral ingestion of isohumulones, bitter components of beer. Biochemical and biophysical research communications. 2017;484(4):740-745. PubMed PMID: 28131837
  9. Gauruder-Burmester A, Heim S, Patz B, et al. Cucurbita pepo-Rhus aromatica-Humulus lupulus Combination Reduces Overactive Bladder Symptoms in Women - A Noninterventional Study. Planta medica. 2019;85(13):1044-1053. PubMed PMID: 31261419
  10. Bradley R, A Staab C, E Jamieson P, et al. Safety and Tolerability of Xanthohumol in Adults With Crohn's Disease: Results of a Triple-Masked, Randomized, Placebo-Controlled Phase 2 Trial. Molecular nutrition & food research. 2026;70(6):e70438. PubMed PMID: 41834265
  11. Jamieson PE, Gu I, Reichart NJ, et al. Modulation of Microbiota-Derived Bile Acids Linked to Symptom Amelioration in Crohn's Disease: Insights From a Randomized Clinical Trial With Xanthohumol Supplementation. Molecular nutrition & food research. 2026;70(10):e70501. PubMed PMID: 42138225

PubMed Topic Searches

  1. PubMed: Xanthohumol human studies

Back to Table of Contents

Key Research: Safety

The U.S. breastfeeding database LactMed states that hops can cause sedation, and lists the use of other sedating drugs and depression as reasons to avoid hops. It describes allergy to hops as rare, and states that “No data exist on the excretion of any components of hops into breastmilk”.

  1. Duncan KL, Hare WR, Buck WB. Malignant hyperthermia-like reaction secondary to ingestion of hops in five dogs. Journal of the American Veterinary Medical Association. 1997;210(1):51-4. PubMed PMID: 8977648
  2. Pfaff A, Sobczak BR, Babyak JM, et al. Retrospective analysis of hops toxicosis in dogs (2002-2014): 71 cases. Journal of veterinary emergency and critical care (San Antonio, Tex. : 2001). 2022;32(1):90-97. PubMed PMID: 34498796
  3. Becker J, Brutlag AG, Hovda L, et al. A retrospective evaluation of hops ingestion in 177 dogs (2005-2018). Journal of veterinary emergency and critical care (San Antonio, Tex. : 2001). 2023;33(3):348-353. PubMed PMID: 36908194
  4. Bates N, Tizzard Z, Edwards N. Hops toxicosis in dogs. Journal of veterinary emergency and critical care (San Antonio, Tex. : 2001). 2022;32(2):274. PubMed PMID: 34850534
  5. Hops. Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PubMed PMID: 30000893
  6. Alkharfy KM, Frye RF. Effect of valerian, valerian/hops extracts, and valerenic acid on glucuronidation in vitro. Xenobiotica; the fate of foreign compounds in biological systems. 2007;37(2):113-23. PubMed PMID: 17484515

PubMed Topic Searches

  1. PubMed: Hops toxicosis in dogs

Back to Table of Contents

External Resources

Back to Table of Contents

Connections

Back to Table of Contents